Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis
about
Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin systemThe B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processingThe Epstein-Barr Virus EBNA1 Protein.Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat.Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis.Severe Deformations of Malignant Bone and Skin Cells, as well as Aged Cells, on Micropatterned Surfaces
P2860
Q33974768-C751C601-BDF6-47CD-9EA0-0991B4E879DDQ34845706-EC2256BF-0FA1-4BC3-9043-0EF433AA8BE5Q35236817-185DC36F-15BE-43B4-8C7D-5EC4452B852FQ35691576-DDE6640E-ADFE-4E28-A0D0-63E9C7B26A5AQ36326008-5BCA3E16-5BF4-472F-84E8-B54503D3E9D8Q36399195-56A1964E-5D5A-4A65-BFB3-7BAC48855EFBQ37142562-5B51452D-EC4E-4E03-8F72-A0088A3ADA3FQ38166365-F9CE62ED-0050-41B5-A360-5A13858D662FQ40625018-7C2861EE-47A8-484E-978A-ED832B48ED32Q41894692-860D2F79-A5B0-4583-B3A4-CD58043EF134Q42917499-B347CB22-6E53-40DB-8A6E-FA2952424510Q44048934-B8C805DD-B0DE-4B9F-BE29-515B571A3947Q44673407-32C36915-E591-458B-B71C-ED92FAA2964AQ45077858-EC5A18EB-4950-4F1A-9D44-A688C7DE55A6Q56947388-12537141-A864-4208-B56F-4E970A7FE1C6
P2860
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@ast
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@en
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@nl
type
label
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@ast
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@en
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@nl
prefLabel
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@ast
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@en
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@nl
P2093
P2860
P50
P356
P1476
Functional p53 chimeras contai ...... and HPV-E6-induced proteolysis
@en
P2093
Ainars Leonchiks
Anatoly Sharipo
Natalia Issaeva
Stijn Heessen
P2860
P304
P356
10.1073/PNAS.022306499
P407
P577
2002-01-22T00:00:00Z